You are here

Clinical Trials: Cord Blood

Condition:   Viral Infection
Intervention:   Biological: HLA-matched VSTs
Sponsors:   Baylor College of Medicine;   The Methodist Hospital System;   Texas Children's Hospital
Not yet recruiting
Conditions:   Stroke;   Umbilical Cord Blood;   Erythropoietin;   Safety;   Treatment Outcome
Interventions:   Drug: Umbilical cord blood infusion;   Drug: Erythropoietin injection;   Drug: Placebo umbilical cord blood infusion;   Drug: Placebo erythropoietin injection;   Procedure: Active rehabilitation
Sponsors:   Bundang CHA Hospital;   Korea Evaluation Institute of Industrial Technology
Conditions:   Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis
Intervention:   Combination Product: Stem Cell Educator therapy combined with minoxidil
Sponsors:   Tianhe Stem Cell Biotechnologies Inc.;   Yale University;   Hackensack Meridian Health
Not yet recruiting
Condition:   Type 1 Diabetes
Intervention:   Combination Product: Stem Cell Educator therapy
Sponsors:   Tianhe Stem Cell Biotechnologies Inc.;   Hackensack Meridian Health
Not yet recruiting
Condition:   Bronchopulmonary Dysplasia
Interventions:   Biological: PNEUMOSTEM®;   Biological: normal saline
Sponsor:   Medipost Co Ltd.
Not yet recruiting
Condition:   Spinal Cord Injuries
Interventions:   Biological: Umbilical Cord Blood Mononuclear Cell;   Drug: Lithium Carbonate;   Other: Placebo;   Other: Locomotor Training
Sponsors:   StemCyte, Inc.;   Amarex Clinical Research
Not yet recruiting
Condition:   Acute Myeloid Leukemia
Intervention:   Biological: Unrelated cord blood
Sponsors:   Ruijin Hospital;   Navy General Hospital of PLA;   Beijing Jishuitan Hospital;   The Affiliated Hospital of Xuzhou Medical University;   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University;   Luoyang Central Hospital;   People's Hospital of Zhengzhou University;   Dongguan People's Hospital;   The First Affiliated Hospital of Xiamen University;   Taian City Central Hospital;   Qilu Hospital of Shandong University (Qingdao)
Conditions:   High Risk Hematologic Malignancy;   Cord Blood Transplant
Intervention:   Biological: Transplant with an expanded ECT-001 cord blood
Sponsors:   Ciusss de L'Est de l'Île de Montréal;   Stem Cell Network (SCN);   Hopital de l'Enfant-Jesus;   Centre Universitaire de Santé McGill;   ExCellThera inc.
Not yet recruiting
Conditions:   Hematological Malignancy;   Acute Leukemia in Remission;   Acute Lymphoblastic Leukemia in Remission;   Myelodysplastic Syndromes;   Non-Hodgkin Lymphoma;   Hodgkin Lymphoma
Interventions:   Biological: Cord blood stem cells;   Drug: Valproic Acid;   Drug: Fludarabine;   Drug: cytoxan;   Drug: Thiotepa;   Biological: TBI
Sponsor:   Alla Keyzner
Conditions:   Diabetes Mellitus, Type 1;   Immunologic Deficiency Syndromes
Intervention:   Procedure: Sequential transplantation
Sponsor:   Children's Hospital of Fudan University
Not yet recruiting